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Background 
 Sleep Related-Breathing Disorders (SBD) in the setting of Heart Failure (HF) can worsen 
HF progression and negatively impact quality of life. Untreated SBD in the setting of HF can 
worsen hypertension, coronary heart disease, and increase the risk of sudden death (Valika & 
Costanzo, 2017).  
Purpose 
 The purpose of this quality improvement (QI) initiative was to develop a process for 
screening HF patients for SBD. This was accomplished by implementing a screening protocol for 
SBD utilizing the STOP-Bang Questionnaire (SBQ) in patients with HF. The desired outcome 
was to increase provider-initiated referrals for sleep studies. It was anticipated that increased 
screening would result in an increase in referrals for formal sleep studies, which could lead to 
improved patient outcomes. 
Methods 
 This quality improvement project involved using a pre-post design to examine the effect 
of screening HF patients for SBD over a 12-week period. This process consisted of 
implementing a screening protocol for SBD that utilizes the SBQ in patients with HF. In 
addition, provider compliance with referring patients for a formal sleep apnea test was measured 




 A paired sample t-test was conducted to explore the compliance of nurses and providers 
screening patients and referring them for sleep studies. An alpha level of 0.05 was utilized. To 
test the hypothesis that pre-implementation referrals (M = 0.83, SD = 1.030) and intra-
implementation referrals (M = 4.58, SD = 3.315) were equal. It should also be noted that both 
conditions were estimated at p < 0.003. This null hypothesis of equal resilience was rejected. 
Thus, it can be can assume that the post-intervention mean was statistically significant and 
higher than the pre-intervention. 
Conclusion 
 The findings of this study support screening of patients with HF for SBD using the SBQ 
to increase referral for sleep studies. It demonstrated statistically significant data showing that 
screening patients for sleep apnea using the SBQ resulted in increased referrals for sleep studies. 
This is important because increasing SBD screening, referrals for sleep studies, and initiating 
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CHAPTER 1: INTRODUCTION 
 Recent studies suggest that SBD contributes to increased mortality in patients with HF 
and worsening prognosis if left untreated (Arzt et al., 2016). Despite the awareness that SBD in 
the setting of HF can worsen HF prognosis, most outpatient clinics still do not routinely screen 
for SBD in the HF population. A study by Senthilvel et al. found that only 2% of outpatient 
providers referred patients for sleep studies (2011). Several national organizations such as the 
American College of Cardiology (ACC), the American Heart Association (AHA), and the Heart 
Failure Society of America (HFSA) have revised their guidelines to stress the importance of 
diagnosing SBD in HF and treating appropriately (Yancy et al., 2017).  
 In patients with HF, screening, diagnosing, and treating SBD is essential, as it improves 
HF progression and mortality (Cowie & Gallagher, 2017; Geib et al., 2015). Utilizing a 
screening tool like the STOP-BANG Questionnaire (SBQ) may increase the number of patients 
who are evaluated for SBD. This screening tool is a short eight-question tool that offers a simple, 
quick, and reliable screening method with an overall sensitivity of 97.6% in detecting SBD (El-
Sayed el at., 2012). Screening may result in an increase in the number of referrals for sleep 
apnea, diagnosis, treatment, and thus improving HF progression and quality of life. To address 
the practice gap in SBD screening and diagnosis in the HF population, this quality improvement 
project will examine the effect of screening on the incidence of SBD identification in the 




 Heart Failure is a progressive and chronic disease caused by the heart's inability to pump 
enough blood and oxygen to meet the body's demand. Approximately 6.5 million adults in the 
United States (US) have been diagnosed with HF, contributing to one in eight of the total death 
counts in 2017 (Centers for Disease Control and Prevention [CDC], 2019). In 2012, the 
estimated cost for HF in the US was 30.7 billion dollars, including healthcare costs, medications, 
and missed workdays (CDC, 2019). Projections have also shown that the prevalence of HF will 
increase by 46% from 2012 through 2030 (Virani et al., 2020).  
 SBD in the setting of HF can worsen HF progression and negatively impact quality of 
life. Untreated SBD in the setting of HF can worsen hypertension, coronary heart disease and 
increase the risk of sudden death (Valika & Costanzo, 2017). Underdiagnosed SBD can also 
promote arrhythmias, obesity, diabetes mellitus, and metabolic disturbances (Holt et al., 2018). 
When SBD is diagnosed in a patient with HF, treatment is based on the form of SBD. Subtypes 
include central sleep apnea (CSA) or obstructive sleep apnea (OSA), which are differentiated by 
obstruction of the airway versus hypo-apnea events while sleeping (Cowie & Gallagher, 2017; 
Geib et al., 2015). 
 Benefits of treating SBD in HF include a decreased risk for cardiovascular events, as well 
as reducing preload, afterload, oxidative stress, inflammatory markers, hypertension, and 
arrhythmias; all of which are known to worsen HF (Tietjens et al., 2019; Holt et al., 2018; Wang 
et al., 2018). Treating SBD in HF has also demonstrated benefits to the heart muscle itself. 
Studies have shown that SBD treatment can decrease left ventricle end-diastolic diameter and 
increase ejection fraction (EF) by eight percent. Decreased EF and increased left ventricle end-
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diastolic diameter are both indications of poor HF prognosis (Schwarz, Scherff, Haile, Steier, & 
Kohler, 2019; Khattak, Hayat, Pamboukian, Hahn, Schwartz, & Stein, 2018).  
 SBD in the setting of HF remains underdiagnosed, and SBD screenings are not frequently 
done. This process improvement will take place in an outpatient clinic in North Carolina, and it 
is proposing to screen HF patients for SBD. Just like many outpatient centers, the site does not 
screen HF patients for SBD but is willing to examine whether implementation of SBD screening 
would be appropriate for this patient population. This clinic is located in a rural community in 
eastern North Carolina with a population of 94,298 in 2019, and 19% were 65 years old and 
older (United States Census Bureau, 2020). The site sees all types of heart conditions, including 
HF, and it is run by nurse practitioners and cardiologists.  
Overview and Prevalence of OSA 
 The overall prevalence of SBD in patients with HF is between 47-76% (Arzt et al., 2016). 
The prevalence of OSA in HF patients is about 12-43% higher than in the regular population, 
and CSA is estimated to be 21-40% (Arzt et al., 2016). SBD is characterized by three different 
patterns: OSA, CSA with Cheyne-stroke respirations (CSA-CSR), or a combination of both, 
known as mixed sleep apnea (MSA). The long-term effects of SBD in HF patients include the 
development or worsening of hypertension, myocardial hypertrophy, atherosclerosis, and 
coronary artery disease, all of which contribute to the worsening of HF (Cowie & Gallagher, 
2017; Geib et al., 2015). 
 SBD is commonly underdiagnosed in patients with HF. Early recognition and diagnosis 
of SBD are associated with improved cardiovascular outcomes, and evidence suggests that 
treating SBD can improve HF outcomes and quality of life. (Arzt et al., 2016). SBD can be 
symptomatic or asymptomatic in patients with HF, and it may be difficult to appreciate on 
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clinical presentation alone. Using a questionnaire to screen for SBD in the HF population may 
provide higher diagnosis rates, as discussed below (Cowie & Gallagher, 2017; Geib et al., 2015).  
Pathophysiology of OSA and CSA in HF 
 OSA is caused by an obstruction of the posterior part of the tongue. When this 
obstruction occurs, the patient experiences OSA hypo-apneas and negative intrathoracic pressure 
as a result of the over-usage of the respiratory accessories muscles. This results in hemodynamic 
changes with an increase of the left ventricle preload and afterload and a decrease in left 
ventricle filling time (Pearse, & Cowie, 2016). Due to the heart's inability to meet the body's 
metabolic demands, other compensatory mechanisms begin to occur, including activation of the 
sympathetic nervous system (SNS) and the release of serum catecholamines (Pearse & Cowie, 
2016).  
 Activation of the SNS is seen in patients with OSA, and there is an over-activation when 
the patient has both OSA and HF, illustrating that OSA can worsen and sometimes cause HF 
(Pearse & Cowie, 2016). Several hemodynamic changes occur with SNS activation, including 
the release of chemicals that increase blood pressure due to stimulation of the renin-angiotensin-
aldosterone system and heart rate due to the release of catecholamines. These same responses are 
seen in patients with HF (Pearse & Cowie, 2016). 
 Unlike OSA, CSA is considered a response to HF as opposed to a cause. In CSA, like in 
OSA, hypo-apnea episodes are compensated by a rise in blood pressure and heart rate. However, 
unlike in OSA, CSA may cause a surge in c-reactive protein (CRP) levels, which are also seen in 
the progression of HF (Pearse & Cowie, 2016). CSA is seen as a marker of worsening HF, unlike 
OSA that tends to cause HF. Some of these hemodynamics are further broken down in Figure 1A 
under Appendix A. 
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 The outcomes of patients treated for SBD in the setting of HF are better than those who 
are undiagnosed. Treatment for SBD is associated with a reduced risk of major cardiovascular 
events and improved quality of life, driven by improved EF, hypertension, arrhythmia burden, 
and overall cardiac function (Schwarz, Scherff, Haile, Steier, & Kohler, 2019; Khattak, Hayat, 
Pamboukian, Hahn, Schwartz, & Stein, 2018).  
Purpose 
 The purpose of this quality improvement initiative was to develop a process for screening 
HF patients for SBD. This was accomplished by implementing a screening protocol for SBD 
utilizing the SBQ in patients with HF. The desired outcome was to increase provider-initiated 
referrals for sleep studies. It was anticipated that increased screening would result in an increase 






CHAPTER 2: REVIEW OF THE LITERATURE  
Search Strategies  
 Several search strategies were utilized to maximize the results. Search terms included 
heart failure, HF, congested heart failure, CHF, sleep apnea, obstructive sleep apnea, OSA, 
central sleep apnea, CSA, mixed sleep apnea, MSA, sleep-related breathing disorder, AND, OR, 
and NOT.  
  Databases included the Cumulative Index to Nursing and Allied Health Literature 
(CINAHL), PubMed, and the CDC. The intent was to keep the search within the past five years. 
However, at completion, the articles ranged from 2008 to the present. Older studies were 
included to explore the history of SBD and HF, as well as to have an accurate comparison of 
how illness management has progressed over time. Studies selected include randomized 
controlled trials (RCT) and systematic reviews. The search was also filtered to include English 
language only and peer-reviewed articles. The initial search yielded a total of 130 articles. After 
filtering for relevant articles, a total of 14 articles were included in the review of the literature.  
Validity of the SBQ Compared to Overnight Polysomnography (PSG) 
 Screening for SBD in HF patients can be difficult when using clinical judgment alone. A 
standardized screening tool, such as the SBQ, may increase referrals and thus increase the 
diagnosis of SBD. Various studies have compared the value of screening tools for SBD. A study 
by El-Sayed et al. compared the SBQ with PSG in diagnosing SBD and found that the SBQ had 
the highest sensitivity of 97.6 % in diagnosing SBD (2012). 
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PSG as the Gold Standard  
 Overnight Polysomnography (PSG) is the gold standard in diagnosing SBD. The PSG 
uses the Apnea-Hypopnea Index (AHI), which is a standard measure for defining the severity of 
OSA and CSA. AHI is the number of apneic events plus the number of hypopneas occurring on 
average each hour. AHI classifies OSA or CSA as mild if the AHI is 5-15 events per hour, 
moderate is 15-30 events per hour, and severe is more than 30 events per hour (Alhougani et al., 
2015). PSG is an expensive diagnostic tool, and not every patient is able to undergo this test. 
PSG requires an in-patient setting where a patient is observed and monitored while they sleep. 
This provides a real-time observation and recording of events that translate to AHI and a 
diagnosis. Home sleep studies may be a more affordable, convenient, and comfortable alternative 
for many patients (Alhougani et al., 2015). Home sleep studies are an alternative to in-patient 
sleep studies and should only be utilized if patients are unable to be tested in an in-patient facility 
as in-patient testing has a greater accuracy, especially for patients with HF (Semelka, Wilson, & 
Floyd, 2016). 
Alternatives to PSG  
 SBQ has established reliability and validity in screening for SBD. An article by 
Alhougani et al. evaluated the validity of the SBQ compared to PSG, finding that 85% of patients 
with an AHI >5 were diagnosed with SBD (2015). Another study by El-Sayed et al. evaluated 
four screening tools for SBD, including the Epworth Sleepiness Scale (ESS), Berlin 
Questionnaire (BQ), STOP Questionnaire (SQ), and the STOP-Bang Questionnaire (SBQ). Each 
participant underwent a PSG study. The SBQ had the highest sensitivity of 97% to diagnose 
SBD when directly compared to the BQ, ESS, and SQ (2012).  
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 The findings of Luo et al. 2014 were consistent with the initial study by Alhougani et al., 
2015. It concluded that the SBQ had the highest sensitivity for mild, intermediate, and high risk 
at 94, 96, and 97%, respectively, compared to the SQ, BQ, and ESS to screen for SBD. 
Similarly, several other studies also looked at the validity and benefits of using the SBQ to 
screen patients for SBD.   
 All studies compared the SBQ with other screening tools for SBD, such as the BQ, the 
Excessive Daytime Sleepiness (EDS), ESS, the Modified Neck Circumference (MNC), the 
Obstructive Sleep Apnea-50 (OSA-50), SDQ, SQ, and the 4 Variable Screening Tool (4-V), as 
demonstrated in under Appendix B, Table 1B. Collectively all of the studies found that the SBQ 
had a calculated mean sensitivity of 97.6 % at detecting SBD and were successful at providing 
evidence that the SBQ is an efficacious tool for screening purposes (Garner et al., 2014; 
Hannallah et al., 2015; Kee et al., 2018; Kim et al., 2015; Luo et al., 2014; Ha et al., 2013; 
Pataka et al., 2014; Senaratna et al., 2019; Shamara et al., 2017; Vries et al., 2015).  
Outpatient Screening for SBD  
 Screening for SBD in the outpatient setting occurs infrequently, as was highlighted by a 
study by Senthilvel et al. 2011 that evaluated if outpatient clinics were inquiring about or 
screening patients for SBD at initial visits. Although there was an adequate sample size of 
patients (n=101), information on the number of participating sites was lacking. They found that 
only a limited sleep history was documented, and 2% of providers made referrals for sleep 
studies. This study shines a light on how infrequently patients are screened for SBD in outpatient 
settings.    
9 
 
Summary of the Literature 
 Early recognition and diagnosis of SBD in the setting of HF is an important factor in 
promoting better outcomes in patients with HF (Arzt et al., 2016). Evidence in the literature 
supports the validity of using the SBQ screening tool to screen HF patients for SBD in the 
outpatient setting. The SBQ has been compared to other SBD screening tools and was the most 
sensitive screening tool for SBD, especially in the HF population. The SBQ was found to have a 
mean sensitivity of 97.6% in detecting SBD. 
 The available literature supports the use of the SBQ to screen for SBD in the HF 
population, increasing the likelihood of diagnosis and improving HF outcomes. Increasing SBD 
screening, referrals for sleep studies, and initiating treatment may improve HF outcomes, 
including decreasing left ventricle end-diastolic diameter, increasing EF, lowering blood 
pressure, reducing preload/afterload, and decreasing the activation of the SNS. These outcomes 
will allow for reduced HF progression and improvement in quality of life (Schwarz, Scherff, 






CHAPTER 3: SCREENING TOOL AND THEORETICAL FRAMEWORK 
Description of the Stop-Bang Questionnaire (SBQ) 
 The SBQ includes four subjective questions, including asking patients about snoring, 
tiredness, observed sleep apnea, and hypertension. In addition, the questionnaire includes four 
demographic questions, including body mass index (BMI), age, neck circumference, and gender. 
The SBQ quantifies SBD risk as low, moderate, or high risk. Each question requires a yes or no 
answer. If patients answer yes to five or more questions, it scores as high risk for SBD. A score 
of three or four is moderate risk, and two or less is low risk for SBD (Chung et al., 2016; Chung 
et al., 2008; Durante et al., 2020; Kee et al., 2018). The University of Toronto, Toronto Western 
Hospital, and University Health Network (UHN) have given the UNC School of Nursing an 
academic license to utilize this screening tool for this practice change. A screening tool 
comparison figure can be seen here under Figure 1, detailing several screening tools for SBD, 














 The theoretical framework for this practice change is the revised version of the Johns 
Hopkins Nursing Evidence-Based Practice (JHNEBP) Model. The JHNEBP has three 
components: inquiry, practice, and learning. Inquiry is the first component and is the foundation 
for questioning, examining, and collecting information about the problem (Dang & Dearholt, 
2017). The second is practice, which addresses the who, what, when, where, and why of what is 
done (Dang & Dearholt, 2017). The third and last component is learning. The learning 
component focuses on continuous learning and how it is necessary to remain current in new 
knowledge, technology, and skills. More details about the JHNEBP can be found in Appendix A, 

















Popular SBD Screening Tools Available Compared
Epworth Sleepiness Scale (ESS), Berlin Questionnaire (BQ), STOP Questionnaire (SQ), The STOP-Bang 
Questionnaire (SBQ), Obstructive Sleep Apnea-50 (OSA-50), 4 Variable Screening Tool (4-V), Sleep Apnea 






CHAPTER 4: METHODS  
Design 
 This quality improvement project involved using a pre-post design to examine the effect 
of screening HF patients for SBD. This process consisted of implementing a screening protocol 
for SBD that utilizes the SBQ in patients with HF. The questionnaire was offered to patients with 
both heart failure with reduced EF (HFrEF) and heart failure with preserved ejection fraction 
(HFpEF). The desired outcomes included an increase in provider-initiated referrals for sleep 
studies. Data collection occurred over a period of 12 weeks to determine the percentage of 
patients who were screened for SBD, the percentage of patients who meet criteria for SBD, and 
the providers' frequency of referrals. Data collected from the referrals sent by the providers were 
then compared with the data from the previous 12 weeks prior to implementation. 
Setting 
 The practice change occurred in an outpatient clinic in eastern North Carolina, 
specializing in cardiology. The clinic is located in a small, rural city, with a population of 
94,298, serving the cardiology needs in Nash County and the surrounding counties of North 
Carolina. Out of the estimated population of 94,298 in 2019, 19% were 65 years old and older 
(United States Census Bureau, 2020). Twelve weeks prior to implementation, on average, the 
clinic saw 84 patients per week, and 38 % or 32 patients per week were seen by a HF specialist. 
 The practice is comprised of five interventional cardiologists, one heart failure 
cardiologist, and three cardiology nurse practitioners. Some of the services offered include 
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general cardiology, interventional cardiology, HF management, as well as an on-site cardiac 
rehabilitation and stress testing. All the cardiologists, nurse practitioners, and staff were educated 
on the practice change. Some of the most common cardiac disorders seen at the site include HF 
with reduced ejection fraction, HF with preserved ejection fraction, atrial fibrillation, valvular 
dysfunction, and post-myocardial infarction management. This clinic sees adult patients age 18 
years old and older.  
 This clinic is a specialty clinic focusing on the care of patients with cardiac disorders and 
does not currently screen HF patients for SBD. This is similar to most outpatient HF clinics 
across the US (Senthilvel et al., 2011). Therefore, it is an ideal setting to implement a screening 
tool for SBD in the HF population. The project will involve administering the SBQ to patients 
with HF and assessing provider compliance. The SBQ is designed to screen for SBD, so patients 
at risk for SBD could be identified and referred for testing (Arzt et al., 2016).  
Intervention 
 The practice did not administer any screening tools or tested patients for SBD. If a 
provider suspected SBD, a referral was made to a local sleep clinic under the direction of a 
neurology sleep specialist. These referrals were initiated based on clinical judgment alone. The 
clinic also offers financial assistance to patients with financial hardship. If a patient cannot afford 
a sleep study, they can apply for financial assistance. Once financial assistance has been 
approved, there are two ways of testing the patient; a home sleep study or an in-patient overnight 
sleep study in one of the affiliated clinics hospitals. The financial assistance program covers both 
options. 
When the patient first arrived, the front desk staff was not able to identify which patient 
had HF. To better identify possible candidates, the nurses read the previous visit notes in 
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anticipation of the next clinic day. This allowed the nurses to identify patients with HF and 
administer the questionnaire when rooming them. The project site staffing varied at times, and 
this could have affected staff adherence with the project. For analysis and tracking purposes, at 
the end of each day, the project champion documented the number and composition of staff and 
patient volume seen that day for the entirety of the implementation period.  
The questionnaire included a checkmark question that asks if the patient has ever had a 
sleep study or if they had ever been prescribed a continuous positive airway pressure (CPAP) 
machine. This prevented screening and referring patients who were being treated for SBD. Then 
the nurse escorted the patient to a treatment room and asked all the necessary questions required 
to complete the SBQ form. At that time, neck circumference was measured to calculate the final 
SBQ score. Providers explained the results to the patients; the decision to refer for a sleep study 
was made through shared decision making if a referral was appropriate. 
 After the provider had discussed the SBQ results and a decision had been made based on 
the patient's score and wishes, the provider initialed the form and checked one of the checkmarks 
indicating a decision. The decision checklist included, yes patient was referred for a sleep study, 
the patient refused a sleep study, the patient does not meet criteria, or the patient had a recent 
sleep study. After the visit was over, the provider made a referral for a sleep study, and the 
nurses collected the forms and placed them in the secure collection bin. 
Key Personnel and Stakeholders 
  Stakeholders for this practice change included the providers, patients, and management of 
the clinic. Key personnel for this project included the receptionist, nurses, and the clinic support 
staff. The clinic staff had a very important role in this practice change, as they delivered the 
questionnaires to patients and then collected them.  
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Provider Education  
 Education for this practice change involved several steps. The student investigator met 
with the providers two weeks before implementation. During this meeting, the student 
investigator provided education regarding detailed information of the literature review and a 
PowerPoint presentation illustrating the physiology and hemodynamics changes seen in OSA 
and CSA in HF patients. The SBQ tool was presented with a demonstration of how to read and 
interpret the scores. Several tables and figures were provided to facilitate provider education 
found under Appendix A, including Table A1, which illustrates the questions seen in the SBQ, 
Table A2 that shows a comparison between sign and symptoms of SBD vs. HF, and Figure A1, 
which illustrates the hemodynamics changes in HF in the setting of SBD. A flyer was also 
provided with details on individuals' responsibility for various aspects of the study. 
 Providers were educated on their responsibilities, including reviewing the SBQ once in 
the room, asking any pertinent questions, and interpreting the score. After the interpretation of 
the score, the providers made a clinical decision as to whether a referral for a sleep study was 
appropriate. Figure A3 detailed the project flow throughout the implementation process.  
Staff Education 
 One week after the meeting with providers, the student investigator had a meeting with 
the clinic staff. The staff was educated on the same topics as providers but with the addition of 
the nurse and staff role.  
 Nurses were responsible for reading the forms, measuring neck circumference, 
calculating the scores, and writing the score on top of the SBQ Form. This was done so that 
when the providers went into the exam room, they will be able to see the completed form. 
During staff training, nurses were educated on a standardized method of measuring the patient's 
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neck circumference for consistency. Every room in the site was stocked with the same reusable 
measuring tape, which was cleaned after each patient encounter. After discussing with the clinic 
nurses, they have all agreed to look at the patient lists a day in advance to determine who had a 
diagnosis of HF.  
 All meetings with the providers and staff were scheduled by the office manager and 
planned two weeks prior to implementation. The clinic was provided with the student 
investigator’s contact information for questions or concerns. Two weeks into the implementation 
period, the student investigator ran a preliminary data analysis of all the data collected until that 
point in time and assessed for staff and provider compliance with the project. This initial analysis 
allowed the student investigator to address any problems that occurred at the beginning of the 
project. Throughout the implementation period, the student investigator scheduled weekly and 
biweekly face-to-face check-ins with the clinic staff, providers, the clinic manager, and with one 
of the project chair members who works in the clinic. These check-ins were intended to address 
any concerns that may have come up during the twelve-week project implementation period. 
Institutional Review Board (IRB) 
 Approval from the Institutional Review Board (IRB) for the University of North Carolina 
at Chapel Hill was obtained on January 19th, 2021. This practice change was focused on the 
provider's behavior and did not constitute research on human subjects. The IRB was informed 
that the practice change was led by a student investigator who was not subjected to any 
compensation from any of the parties involved. Once approval was obtained, the student 
investigator remained in compliance with all policies and submitting any changes to the protocol. 






CHAPTER 5: DATA ANALYSIS 
Data Collection 
 At the end of each clinic day, one of the project champions collected all the completed 
SBQ forms and placed them inside of a folder in a locked office. The forms were also inside a 
locked drawer located in the same clinic. Once per week, the student investigator was 
responsible for going to the clinic and extracting data from the packets.  
  A Microsoft Excel document was created to extract all the data, including the number of 
forms collected, patients’ risk for SBD, date of visit, the last four numbers of their medical 
record number, and whether a referral is indicated, in addition to the answer to all of the eight 
questions of the SBQ. This same Microsoft Excel document was encrypted and protected with a 
password; all data collected were de-identified. Also, every patient was assigned a unique 
identifier number for further data protection. After data extraction, the completed SBQ forms 
were destroyed using the clinic secure paper disposal bin, and the encrypted digital data was kept 
in the Microsoft Excel document under a secure OneDrive account. This account was secured by 
standards set by the information technology (IT) department of the UNC School of Nursing and 
in compliance with the UNC IRB. Access to the OneDrive account and Microsoft Excel 
document was granted to the DNP committee members for research purposes only. If the 
OneDrive account was accessed outside of the project site setting, it was done so over a network 
connection using secure methods such as a password and VPN. Computers accessing study data 
also had an endpoint protection installed and updated regularly. 
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 After the implementation period, the data will remain in the secure OneDrive for a three-
year period. At the three-year mark, the student investigator will then communicate with the 
office manager about any further data utilization; if no further use is needed, the OneDrive data 
will be permanently deleted. 
 Before implementation, the office manager provided two EPIC-generated de-identified 
lists detailing the number of patients seen in the clinic in the past three months, as well as one 
that shows how many referrals for sleep studies have been ordered, accounting for internal or 
external referrals in the same timeline. These de-identified lists were filtered to include only 
patients seen by HF providers. After the three-month implementation period, the same two 
EPIC-generated de-identified lists were generated for data analysis. A report of the findings was 
organized and shared with the clinic staff at one of their staff meetings. This report, along with 
the data collected, will remain in the same secured OneDrive for three years after 
implementation. 
Data Analysis 
 Descriptive statistics were used to analyze the data. Descriptive data were reported via a 
two-proportion t-test using SPSS in Microsoft Excel; data points were compared with the pre-
versus-post intervention. A paired sample t-test was conducted to explore the compliance of 
providers screening patients for SBD and sending referrals for sleep studies. An alpha level of 
0.05 was utilized. To test the hypothesis that pre-implementation referrals (M = 0.83, SD = 
1.030) and intra-implementation referrals (M = 4.58, SD = 3.315) were equal. The assumption 
was considered satisfied since the skew and kurtosis were estimated at -0.022 and -1.264. It 
should also be noted that both conditions were estimated at p < 0.003. This null hypothesis of 
equal resilience was rejected. Thus, the post-intervention mean was statistically significant and 
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higher than the pre-intervention. Cohen’s d was estimated at 3.746. Descriptive statistics can be 
visualized below under Table 1. More statistical data can be found under Table A4, as well as in 
Table A5 and Table A6.  
Table 1: Paired Samples Statistics for Referrals Sent Pre vs. Intra-
Implementation 
 Mean N Std. Deviation Std. Error Mean 
Pair 1 Referral Sent Pre-
Implementation 
.83 12 1.030 .297 
Referral Sent Intra-
Implementation 







CHAPTER 6: DISCUSSION  
Ethical Considerations 
 Every patient had the option to decline the screening tool. The project was designed to do 
no harm, as this was only a screening tool. The screening tool had a disclaimer at the beginning 
of the page, stating its purpose. The final version of the screening tool can be found under 
Appendix A, Figure A7. All patient records and screening tools were kept confidential and were 
compliant with the Health Insurance Portability and Accountability Act (HIPAA). After 
screening, if a referral was appropriate but, the patient was unable to undergo a sleep study either 
because of affordability or because of lack of insurance, the clinic offered its financial assistance 
program. In addition to consulting with case management or their social worker to find any other 
financial assistance available.  
Limitations  
 One limitation of this project included some stakeholder’s compliance and participation. 
Education about current research and data showing the benefits of the implementation, in 
addition to open and continuous communication with staff, providers, and the office manager 
was crucial in addressing this limitation. Another way this limitation was addressed was by using 
the Practice Question, Evidence, Translate (PET) Process of the JHNEBP model. This method 
was used two weeks into the project implementation to analyze nurse’s compliance. 
 Another limitation was provider time restrictions. Not every patient was always able to be 
screened when the provider was running behind. Some providers chose to focus on more acute 
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concerns during the visit instead of looking at the SBQ. Some providers deferred the screening 
tool for another visit or kept the form to send the referral later that day. If the providers kept a 
form, the nurses made sure that the form was placed in the locked drawer by the end of the day. 
To assist with this limitation, the clinic staff was educated on a fast and effective way of 
administering the screening tool, and there were weekly check-ins with providers to determine 
the flow of the practice change. 
Project Barriers 
 Barriers to this practice change included low patient sample size, patients’ inability to 
read the screening tool or nurses not having enough time to complete it with patients. Several 
times during the implementation period the nurses forgot to screen their patients. Another barrier 
was that in the middle of the implementation period the clinic hired a new nurse because they 
were short-staffed. This new nurse missed a few screening opportunities, but this was also 
addressed, and educational material was provided. The student investigator realized that the 
problem with nurse’s compliance was caused by not having the screening tool easily available 
and not having enough reminders. After this realization, the nurses were given a verbal 
questionnaire regarding ways of improving compliance. 
 Following this questionnaire, several changes occurred. To fix the issue with the 
screening forms availability, the student investigator changed the color of the screening tool to 
pink and added a stack of forms to each clinic room. In addition to the change in the color of the 
form, text in the form was reformatted to highlight important screening questions. The nurses 
also complained of not having enough reminders. This was addressed by having the student 
investigator increasing the in-person visits to twice a week and promote open communication 
with the staff. Reminder and encouraging emails were sent twice a week for the remainder of the 
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implementation period. These changes significantly improved nursing compliance with screening 
patients, as can be appreciated below under Table 2. 
Table 2: Nurses Compliance with Screening Patients  
 
 Financial burden could be one of the most challenging barriers to this practice change, as 
some patients may decline interventions due to affordability. Patients had an option to apply for 
financial assistance with medical billing and testing. So, if there were concerns about a financial 
burden, this option was presented to the patient.  
 Other barriers included an unwillingness of patients to participate in the screening or 
inaccurate self-reporting. On very few occasions, some providers deferred the screenings to other 
visits. Some future barriers that can be expected would be for some patients to refused to take the 
SBQ, having a formal sleep study, or adhere to treatment if a diagnosis of SBD is established.  
 An additional barrier was that a paper form of the SBQ had to be utilized. To make this 
project sustainable, the student investigator created an EPIC dot phrase at the end of the 



























































nurses open a premade dot phrase that would allow them to click yes or no, enter the neck 
circumference, and calculate a score, allowing for a faster screening process and easier tracking 
of data. 
Implementation Flow 
 After a referral was ordered by a provider for a formal sleep study evaluation, given the 
current measures in place due to Corona Virus Disease-2019 (COVID-19) pandemic, patients 
had a choice of either a phone or a video visit. This allowed the patients to have a more 
affordable and easier experience. If the patient was offered to get a formal sleep study by the 
sleep specialist, they had the option to travel to a nearby city or have their sleep study done near 
the HF clinic. Patients had the option to have their sleep studies done as in-patient in the sleep 
study labs as previously mentioned or using a home sleep study method. The decision was 
guided by the provider and the patient, as the provider or patient may have a preferred testing 
modality. Both in-patient or home studies are capable of diagnosing SBD, but sometimes the 
decision is impacted by affordability and availability. Most home sleep studies are covered by 
insurance, while in-patient sleep studies are less likely to be covered by insurance due to higher 
costs.  
 Another factor to consider is the benefits of treatment if a diagnosis of OSA is made. The 
patient can be educated on the benefits and options available; if financial burden is still a 
problem, they may be seen by a social worker to find further financial help and avenues. As to 
the harm to treat or not to treat, is a discussion that the patient should have with their provider. 
As previously stated, the diagnosis of SBD and treatment can promote a decrease in mortality 




 The Implementation period lasted a total of three months. Data collection began on 
February 22, 2021 and concluded on May 14, 2021.  During this time, a total of 423 patients were 
seen in the clinic, compared to 382 that were seen three months prior to implementation. Intra-
Implementation had a greater number of patients seen, and suspect that this is related to fewer 
holiday that occurred during this phase compared to the pre-implementation period. On the other 
hand, the difference in the number of patients seen may be related to fewer patients seen during 
the COVID19 pandemic lockdown and after in-patients’ office visits restrictions were lifted, the 
number of visits increased accordingly. 
 Measuring provider compliance with referring patients for sleep studies after looking at 
the SBQ was one of core measurements of this DNP Project. The compliance with referrals was 
significantly higher during the intra-implementation period with 55 referrals compared to the 
pre-implementation period that only had ten referrals. This significant change in practice 
indicates that this DNP Project had positive results. A comparison chart showing pre vs. intra-
implementation referrals is represented under Table 3, and Table 4, as well as gender, found 
under Figure A6. Figures comparing patient's responses to having a history of sleep apnea can be 
found under Figure A5. Bars figures comparing patients scoring high vs. low on the SBQ can 







Table 3: Percentage of Referrals Sent Pre vs. Intra-Implementation   
 
Table 4: Referrals Sent Pre vs. Intra-Implementation   
 
 The SBQ form was slowly adapted by the nurses, and after a few modifications to the 
form and several discussions with the clinic staff, screening remained at a constant level past 
week five of the implementation period. During the 12 weeks pre-implementation, a total of 382 


































































weeks of intra-implementation, a total of 423 patients were seen by a HF provider. Out of the 
patients seen intra-implementation, 274 were screened using the SBQ, and 55 referrals were sent. 
To make sure there were not any duplicate SBQ screenings, a filter was applied to exclude any 
repeated screens. After this filter was applied, a total of 196 patients were screened. From the 
referrals sent intra-implementation, 36 referrals or 66% were males and 18 referrals or 34% were 
females. A chart about male versus females can be found under figure A6. 
 After all the SBQ forms were analyzed, there were a total of 196. It can be further broke 
down to compare high risk versus low risk. Of the 196 patients, 22 were scored as low risk, and 
174 were high risk. Detailed descriptive statistics about each individual question of the SBQ can 
be found in Table A4, Table 5, and Table 6. Patients were also asked if they had ever been 
diagnosed with SBD in the past or had been ordered a CPAP machine to sleep with. 68 out of the 
196 patients answered yes to having a history of SBD, and 128 answered no. With this 
information, it can be depicted that many of the patients screened as high risk, and very few 
reported having a sleep study in the past. A separate chart illustrates the patient’s answer to each 
of the eight individual questions and can be appreciated below under Table 5. 
Project Sustainability 
 This Project focused on measuring provider compliance with screening HF patients for 
SBD. The study period was too brief to allow for follow up on the number of patients completing 
sleep study referrals, nor the number of patients actually diagnosed with SBD’s. Future studies 
might focus on these outcomes. A sequent study can be formulated where it can measure the 
number of patients who were diagnosed with SBD. There can also be a longer study that would 
determine the correlation between a diagnosis/treatment of SBD and the patient’s progression of 
HF and determining if there is an improvement in quality of life. 
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Table 5: Patients Answers to the SBQ Questions Compared 
 
Conclusion 
 This practice change involved implementing a practice change that promoted provider 
compliance with screening HF patients for SBD using the SBQ. The evidence supported the 
SBQ as a valid and reliable screening tool for SBD, with a sensitivity of 97.6%. The desired 
outcomes of this project were to increase awareness and identification of patients with SBD, and 
provider compliance with referring patients for sleep studies.  
 This DNP Project highlights the importance of screening HF patients for SBD using the 
SBQ screening tool. Using the SBQ showed improvement in provider compliance with screening 
patients for SBD. This is important because as previously mentioned, increasing SBD screening, 
referrals for sleep studies, and initiating treatment may lead to improved HF outcomes, including 
decreasing left ventricle end-diastolic diameter, increasing EF, lowering blood pressure, reducing 
preload/afterload, and decreasing the activation of the SNS. These outcomes will allow for 













































 The findings of this Project support formalizing a practice change where all HF patients 
are screened for SBD. This project could lead to positive health outcomes for HF patients and 
promotes screening patients for SBD at minimal cost and allows for shared-decision making 






Table A1: Questions Found Under the STOP-Bang Questionnaire  
 
 




Table A2: Sign and Symptoms Found on HF vs SBD Compared 
 
 
Note. This table illustrates the signs and symptoms of SBD in HF patients and compares between 




Table A3: DNP Project Timeline 
 
 
Note. This table provides with tentative dates of every step of the DNP Project as a timeline. 





Table A4: Descriptive Statistics of Pre vs. Intra-Implementation 
Referrals  
Descriptive Statistics of Pre vs Intra-Implementation Referrals 
 
Referral Sent Pre-
Implementation Referral Sent Intra-Implementation 
N Valid 12 12 
Missing 0 0 
Mean .83 4.58 
Median .50 3.50 
Mode 0 2a 
Std. Deviation 1.030 3.315 
a. Multiple modes exist. The smallest value is shown 
 
 
Paired Samples Correlations 
 N Correlation 
Significance 
One-Sided p Two-Sided p 










Table A5: Descriptive Statistics T-Test of Pre vs Intra-Implementation 
Referrals 
Paired Samples Test of Descriptive Statistics of Pre vs. Intra-Implementation Referrals 
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Table A6: Descriptive Statistics of Questions of the SBQ Individualized  
Group Statistics of All Questions in the SBQ 
 Risk Score N Mean Std. Deviation Std. Error Mean 
Question1 Low Risk Score 22 .36 .492 .105 
High-Risk Score 174 .52 .501 .038 
Question2 Low Risk Score 22 .73 .456 .097 
High-Risk Score 174 .70 .462 .035 
Question3 Low Risk Score 22 .32 .477 .102 
High-Risk Score 174 .27 .445 .034 
Question4 Low Risk Score 22 .91 .294 .063 
High-Risk Score 174 .87 .333 .025 
Question5 Low Risk Score 22 .27 .456 .097 
High-Risk Score 174 .40 .491 .037 
Question6 Low Risk Score 22 .77 .429 .091 
High-Risk Score 174 .81 .393 .030 
Question7 Low Risk Score 22 .55 .510 .109 
High-Risk Score 174 .64 .480 .036 
Question8 Low Risk Score 22 .59 .503 .107 
High-Risk Score 174 .60 .491 .037 
 























































Figure A3: QI Project Flow Diagram 
 
 
Note. This figure illustrates the DNP Practice change flow. It was developed to guide the 





Figure A4: Bar Chart Comparing Patients as High vs. Low Risk Score for SBD  
 


























Figure A5: Bar Chart Detailing History of Sleep Apnea 
 
 





Figure A6: Gender of Patients Sent for Referrals Intra-Implementation  
 
 






Figure A7: Sleep-Related Breathing Disorder Screening Tool 
Disclosure Statement 
 
INTRODUCTION: This research tool will ask questions about your sleeping habits, blood pressure, 
weight, age, and gender. The purpose of the study is to promote a screening tool aimed at screening 
patients for Sleep-Related Breathing Disorder (SBD). It is not diagnostic; it is strictly designed as a screen 
method. 
PARTICIPATION: Taking this screening tool is completely voluntary. You may stop your participation 
at any time. You are free to decline to answer any question you do not wish to answer. There are no right 
or wrong answers. All answers will remain completely confidential. 
CONFIDENTIALITY: Your name or identity will not be used in reports or presentations of the findings 
of this research. Information provided to the researchers will be kept confidential. This research project 
has been approved by the Institutional Review Board at The University of North Carolina at Chapel Hill. 
Any decision to pursue any further studies or treatment will be deferred to your providers discretion.    

















For concerns about this screening tool, please contact: 
Graduate Student Name: Henry Delgado Avila  
Graduate Student Phone: (305) 989-4877 
Email: Henry2@ad.unc.edu 
School Address: UNC at Chapel Hill, School of Nursing 




STOP-BANG Questionnaire (SBQ) 
 
 
Height _____ in/cm     Weight _____ lb/kg     Age _____                                   Date: _______________ 
Male/Female 
BMI _____  
Neck circumference _____ cm                                                                              Last Four of MRN: _____ 
 
1. Snoring 
Do you snore loudly (louder than talking or loud enough to be heard through closed doors)? 
_____ Yes or _____ No 
2. Tired 
Do you often feel tired, fatigued, or sleepy during daytime? _____ Yes or _____ No 
3. Observed 
Has anyone observed you stop breathing during your sleep? _____ Yes or _____ No 
4. Blood Pressure 
Do you have or are you being treated for high blood pressure? _____ Yes or _____ No 
5. BMI 
BMI more than 35 kg/m2? _____ Yes or _____ No 
6. Age 
Age over 50 yr old? _____ Yes or _____ No 
7. Neck circumference 
Neck circumference greater than 40 cm? _____ Yes or _____ No 
8. Gender 
Gender male? _____ Yes or _____ No 
 
_____ High risk of SBD: Yes to ≥ 3  
                          OR 
_____ Low risk of SBD: Yes to < 3 
_____Has the patient ever had a sleep study or currently treated for SBD? 




Table B1: Sleep-Related Breathing Disorder (SBD) Screening Tools 
Comparison 
Sleep-Related Breathing Disorder (SBD) Screening Tools Comparison  











To screen ≥ 
18 y/o for who 
are at high 





















§ Snoring behaviors 
§ Daytime 
sleepiness/Tiredness 
§ Body size (BMI>30 
kg/m2) 
§ Hypertension  
 
  
Number of items: 11 
items grouped in 3 
categories. 
 
Type of Items:  
§ Yes/no questions  
§ Multiple options   
 
Category 1: (items 2, 
3, 4, 5, 6). Scores 
range 0-6; if score > 2 
then (+) 
Category 2: (items 7, 
8, 9). Scores range 0-
3; if score > 2 then 
(+) 
Category 3: (item 10, 
11; BP & BMI). If 
either ‘yes’ to both or 
either, then (+). 
 
*Note: Blood 
Pressure (BP) is 
determined by a 
current or previous 
history of 
Hypertension (HTN) 
*Note: BMI is 
calculated by provider 
using visit values. 
 
If 2-3 categories (+) it 

































If 0-1 categories are 




























Number of items: 8 
items 
 
Types of items: 
§ 4 options (0-4) per 
question 
§ Max possible 
number of Points 
when added is 24 
 
Options to pick from, 
per question:  
§ 0 = Never Dozes 
off 
§ 1 = Slight Chance 
of Dozing off 
§ 2 = Moderate 
Chance of Dozing 
off 
§ 3 = High Chance 
of Dozing off 
 
Scoring ESS, when all 
points are added: 
§ 0-5 Lower Normal 
Daytime 
Sleepiness 
§ 6-10 Higher 
Normal Daytime 
Sleepiness 













































To screen ≥ 
18 y/o for who 
are at high 















with the ESS. 
 
Characteristics: 
§ Snoring behavior 
§ Age  
§ Breathing Pause 




Number of items: 4 
 
Type of items: Yes-
No Questions  
 
Item 1 and 2 (Scores 
3 points each)   
Item 3 and 4 (Scores 
2 points each) 
 
Score ≥ 5 (out of the 
10) indicative of High 
































To screen ≥ 
18 y/o for who 
are at high 











§ Sleep habit  
§ Sleep duration  
§ Sleep Pattern  
 
 
Number of items: 9 
items grouped in 4 
categories and 7 
components  
 
Type of Items:  
§ Yes/no questions  
§ Multiple options   
 
Category 1: (items 1-
4). General self-
responses about sleep   
Category 2: (item 5). 
Asks about Trouble 
with Sleep, 
Subdivided from A 
through J.  
§ Nothing during 






























by a provider.   
 
Can be very 
complex to fill 
out  
 
§ < Once on a week 
= 1 
§ Once or Twice per 
week = 2 
§ ≥ Three per week 
= 3 
Category 3: (item 6-
8). Follow same 
format as Category 2 
per question 
Category 4: (item 9). 
Asks about Rating 
Sleep  
§ Very good = 0 
§ Fairly good = 1 
§ Fairly bad = 2 
§ Very bad = 3 
 
Components 1: Sum 
on item 9 (0-3 Points) 
Components 2: Sum 
on item 2 + 5a (0-3 
Points) 
Components 3: Sum 
on item 4 (0-3 Points) 
Components 4: (total 
# of hours asleep) / 
(total # of hours in 
bed) x 100 
Components 5: Sum 
on items 5b + 5j (0-3 
Points) 
Components 6: Sum 
on item 6 (0-3 Points) 
Components 7: Sum 
on items 7 + 8 (0-3 
Points) 
 
Scoring: Adding all 
Components together 
= (Global PSQI 
Score) 
§ Range 0-21 
points, the higher 
the number the 
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worst the sleep 
quality is. 
 
*Note: Questions are 
driven by the past 







To screen ≥ 
18 y/o for who 
are at high 






High Risk vs. 
Moderate Risk 














by a provider.   
 
Characteristics: 
§ Snoring behaviors 
§ Daytime 
sleepiness/Tiredness 
§ Body size (BMI>30 
kg/m2) 







Number of items: 8 
items  
 




represents 1 point  
§ Some values are 
self-reported or 
obtain during visit 
(BMI) 
 
Item 1: Asks about 
Snoring (Yes or No) 
Item 2: Asks about 
Tiredness (Yes or No) 
Item 3: Asks about 
Breathing cessation 
while sleeping (Yes 
or No) 
Item 4: Asks about 
HTN (Yes or No)  
Item 5: Asks about 
BMI > 35 kg/m2 (Yes 
or No) 
Item 6: Asks about 
Age > 50 y/o (Yes or 
No)  
Item 7: Asks about 
Neck circumference > 
40 cm (Yes or No)  
Item 8: Asks about 
Gender: Males (Yes 

































- If answered 
Yes to ≥ 5 out 
of 8 = High 
SBD Risk 
- If answered 
Yes to 3 or 4 
out of 8 = 
Moderate 
SBD Risk 
- If answered 
Yes to ≤ 2 out 




*Note: BP is 
determined by a 
current or previous 
history of HTN 
*Note: BMI and Neck 
Circumference is 
calculated by provider 
using visit values. 
 
If 2-3 categories (+) it 
= High Risk for SBD  
If 0-1 categories are 







To screen ≥ 
18 y/o for who 
are at high 






High Risk vs. 
Low Risk 
Characteristics: 
§ Snoring behaviors 
§ Daytime 
sleepiness/Tiredness 
§ Body size (BMI>30 
kg/m2) 









Number of items: 4 
items  
 
Type of Items:  
§ Yes/no questions  
§ Self-reported or 
obtain during visit 
(BMI) 
 
Item 1: Asks about 
Snoring (Yes or No) 
Item 2: Asks about 
Tiredness (Yes or No) 








































by a provider.   
 
while sleeping (Yes 
or No) 
Item 4: Asks about 
HTN (Yes or No)  
 
Scoring: 
§ If answered Yes 
to ≥ 2 out of 4 = 
High SBD Risk 
§ If answered Yes 
to < 2 out of 4 = 
Low SBD Risk 
 
*Note: BP is 
determined by a 
current or previous 
history of HTN 
*Note: BMI and Neck 
Circumference is 
calculated by provider 







BMI: Body Mass Index; BQ: Berlin Questionnaire; ESS: Epworth Sleepiness Scale; HTN: 
Hypertension; OSA-50: Obstructive Sleep Apnea-50; SBD: Sleep-related Breathing Disorder; 
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